文献速递中毒与环境急症重症综合管理与镇静镇痛

氯丙嗪过量:病例系列研究

Chlorpromazine overdose: a case series.
PubMed 文献 · Clin Toxicol (Phila) · 2024-06-18
一句话结论氯丙嗪过量以中枢神经系统抑制最常见,气管插管与更大报告摄入剂量相关,尤其在单药过量时。

该研究回顾性分析1987至2023年一家毒理学三级转诊医院收治的218例氯丙嗪过量(报告摄入剂量大于300 mg)患者。中位报告摄入剂量为1,250 mg(四分位距700-2,500 mg),62%报告合并其他药物摄入。50例(23%)入住重症监护室,32例(15%)接受气管插管;插管患者的中位报告摄入剂量为2,000 mg(四分位距1,388-3,375 mg),显著高于未插管患者的1,200 mg(四分位距644-2,050 mg;P < 0.001)。作者认为氯丙嗪过量最常见效应为中枢神经系统抑制,气管插管与更大报告摄入剂量相关。

要点

  • 氯丙嗪过量以中枢神经系统抑制最常见,218例中36例(27%)格拉斯哥昏迷评分小于9分。
  • 50例(23%)入住重症监护室,其中超过一半接受气管插管;32例(15%)接受气管插管。
  • 插管患者中位报告摄入剂量2,000 mg(四分位距1,388-3,375 mg) vs 未插管患者1,200 mg(四分位距644-2,050 mg),P < 0.001。
  • 单药氯丙嗪过量中7例插管者的中位报告摄入剂量为2,500 mg(四分位距2,000-8,000 mg,范围1,800-20,000 mg)。
  • 18例(8%)出现谵妄,8例(4%)出现低血压(收缩压小于90 mmHg),3例出现癫痫发作,1例死亡。

适用人群与场景

  • 1987至2023年入住毒理学三级转诊医院的氯丙嗪过量患者,报告摄入剂量大于300 mg。
  • 中位年龄32岁(四分位距25-40岁),143例(61%)为女性。

诊断标准与关键阈值

  • 报告摄入氯丙嗪剂量大于300 mg作为纳入标准。
  • 低血压定义为收缩压小于90 mmHg。
  • 格拉斯哥昏迷评分小于9分作为临床效应指标。

红旗征与不能漏的情况

  • 格拉斯哥昏迷评分小于9分(36例,27%)。
  • 低血压(收缩压小于90 mmHg,8例,4%)。
  • 谵妄(18例,8%)、癫痫发作(3例)、死亡(1例)。

研究设计与关键结果

  • 回顾性分析218例氯丙嗪过量病例,36年间就诊频率下降,2013年后报告摄入剂量亦下降。
  • 中位报告摄入剂量1,250 mg(四分位距700-2,500 mg);135例(62%)报告合并其他药物摄入,常见为苯二氮䓬类、对乙酰氨基酚或抗精神病药。
  • 76例(35%)为单药氯丙嗪过量,其中位报告摄入剂量1,650 mg(四分位距763-3,000 mg),高于合并摄入组的1,200 mg(四分位距700-2,100 mg)。
  • 插管患者中位报告摄入剂量2,000 mg(四分位距1,388-3,375 mg) vs 未插管患者1,200 mg(四分位距644-2,050 mg),P < 0.001。
  • 入住重症监护室与未入住重症监护室患者的中位报告摄入剂量差异有统计学意义,P < 0.0001。
  • 单药氯丙嗪过量中7例插管者的中位报告摄入剂量为2,500 mg(四分位距2,000-8,000 mg,范围1,800-20,000 mg)。
  • 18例(8%)出现谵妄,8例(4%)出现低血压,3例出现癫痫发作,1例死亡。

证据类型、等级与局限

  • 证据类型:回顾性病例系列研究。
  • 局限:回顾性设计;无摄入口服分析确认。

对床旁实践的改变

  • 作者认为氯丙嗪过量最常见效应为中枢神经系统抑制;气管插管与更大报告摄入剂量相关,尤其在单药过量时。
  • 入住重症监护室或插管的决定基于临床需要,但报告摄入剂量与气管插管需求存在显著关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Chlorpromazine, one of the oldest antipsychotic medications, remains widely available and is still taken in overdose. We aimed to investigate the clinical effects of chlorpromazine overdose and determine if there is a relationship between the reported dose ingested and intensive care unit admission or endotracheal intubation.

METHODS: We performed a retrospective analysis of patients admitted to our toxicology tertiary referral hospital with chlorpromazine overdose (reported dose ingested greater than 300 mg) between 1987 and 2023. We extracted demographic information, details of ingestion, clinical effects and complications (Glasgow Coma Scale, hypotension [systolic blood pressure less than 90 mmHg], delirium, dysrhythmias), length of stay, intensive care unit admission, and endotracheal intubation.

RESULTS: There were 218 chlorpromazine overdose cases, with presentations decreasing in frequency over the 36 years. The median age at presentation was 32 years (interquartile range: 25-40 years) and 143 (61 per cent) were female. The median reported dose ingested was 1,250 mg (interquartile range; 700-2,500 mg). The majority of presentations (135; 62 per cent) involved reported co-ingestion of other medications, typically benzodiazepines, paracetamol or antipsychotics. There were 76 (35 per cent) chlorpromazine alone ingestions in which there was a slightly higher median reported dose ingested of 1,650 mg (interquartile range: 763-3,000 mg) compared to the reported co-ingestion group, median reported dose ingested of 1,200 mg (interquartile range: 700-2,100 mg). Of all presentations, 36 (27 per cent) had a Glasgow Coma Scale less than 9, 50 (23 per cent) were admitted to the intensive care unit, and 32 (15 per cent) were endotracheally intubated. There was a significant difference in the median reported dose ingested between patients intubated (2,000 mg; interquartile range: 1,388-3,375 mg) and those not intubated (1,200 mg; interquartile range: 644-2,050mg; P < 0.001), and between those admitted to the intensive care unit and not admitted to the intensive care unit (P < 0.0001). The median reported dose ingested in seven chlorpromazine alone presentations who were intubated was 2,500 mg (interquartile range: 2,000-8,000 mg, range: 1,800-20,000 mg). Eighteen (8 per cent) patients developed delirium, eight (4 per cent) had hypotension, three had seizures, and there was one death.

DISCUSSION: Almost one quarter of cases were admitted to the intensive care unit and over half of these were intubated. Whist the decision to admit to an intensive care unit or intubate a patient is based on clinical need, there was a significant association between reported dose ingested and requirement for endotracheal intubation. Both the frequency of presentation and reported dose ingested declined after 2013. The major limitations of the study were a retrospective design and no analytical confirmation of ingestion.

CONCLUSIONS: We found that the most common effect of chlorpromazine overdose was central nervous system depression and that endotracheal intubation was associated with larger reported doses ingested, particularly in single chlorpromazine ingestions.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Berling I, Isbister GK. Chlorpromazine overdose: a case series. Clin Toxicol (Phila). 2024. PMID: 38889430. doi:10.1080/15563650.2024.2367672

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。